Venetoclax-based combination therapy as a bridge to allogeneic hematopoietic cell transplant in children with relapsed/refractory AML

被引：0
|
作者：
Pfeiffer, Thomas [1 ]
Li, Ying [1 ]
Karol, Seth E.
Rubnitz, Jeffrey E. [2 ]
Epperly, Rebecca [1 ]
Madden, Renee [1 ]
Mamcarz, Ewelina [1 ]
Obeng, Esther A. [1 ]
Qudeimat, Amr [1 ]
Sharma, Akshay [1 ]
Srinivasan, Ashok [1 ]
Suliman, Ali [1 ]
Talleur, Aimee C. [1 ]
Velasquez, Mireya Paulina [1 ]
Gottschalk, Stephen [1 ]
Triplett, Brandon M. [1 ]
Naik, Swati [1 ]
机构：
[1] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Theraphy, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Outcomes of HMA and Venetoclax in Relapsed AML Post-Allogenic Hematopoietic Stem Cell Transplant
    Diab, Osama
    Abdelhakim, Haitham
    McGuirk, Joseph P.
    Lin, Tara
    BLOOD, 2020, 136
  • [32] Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation
    Zucenka, Andrius
    Vaitekenaite, Vilmante
    Maneikis, Kazimieras
    Davainis, Linas
    Pileckyte, Regina
    Trociukas, Igoris
    Peceliunas, Valdas
    Zvirblis, Tadas
    Staras, Vytautas
    Griskevicius, Laimonas
    BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2804 - 2812
  • [33] Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation
    Andrius Zucenka
    Vilmante Vaitekenaite
    Kazimieras Maneikis
    Linas Davainis
    Regina Pileckyte
    Igoris Trociukas
    Valdas Peceliunas
    Tadas Zvirblis
    Vytautas Staras
    Laimonas Griskevicius
    Bone Marrow Transplantation, 2021, 56 : 2804 - 2812
  • [34] GO-FLAG Regimen as a Bridge Therapy to Allogeneic Stem Cell Transplantation in Refractory/relapsed AML Patients
    Ayubova, Bella
    Bondarenko, Sergey
    Moiseev, Ivan
    Uspenskaya, Olga
    Karyagina, Elena
    Misyurina, Elena
    Zhelnova, Evgenia
    Alyanskiy, Alexander
    Babenko, Elena
    Barkhatov, Ildar
    Gindina, Tatyana
    Kulagin, Alexander
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 197 - 197
  • [35] Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients
    Zappasodi, P.
    Brociner, M.
    Merati, G.
    Nizzoli, M. E.
    Roncoroni, E.
    Boveri, E.
    Castagnola, C.
    Arcaini, L.
    ANNALS OF HEMATOLOGY, 2021, 100 (04) : 1111 - 1113
  • [36] Optimal Therapeutic Strategies in Relapsed/Refractory AML with Prior Exposure to Venetoclax Based Therapy
    Bawek, Sawyer
    Patel, Prutha
    Wang, Katy
    Attwood, Kristopher
    Cronin, Tara
    Fos, Melissa
    Green, Steven
    Sung, Pamela Jeannette
    Thompson, James E.
    Griffiths, Elizabeth A.
    Wang, Eunice S.
    Przespolewski, Amanda C.
    BLOOD, 2023, 142
  • [37] Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients
    P. Zappasodi
    M. Brociner
    G. Merati
    M. E. Nizzoli
    E. Roncoroni
    E. Boveri
    C. Castagnola
    L. Arcaini
    Annals of Hematology, 2021, 100 : 1111 - 1113
  • [38] Feasibility and safety of Venetoclax-based bridging to allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) for high-risk Acute Myeloid Leukemia (AML)
    Pabst, C.
    Sauer, T.
    Stadtherr, P.
    Hegenbart, U.
    Luft, T.
    Hundemer, M.
    Schlenk, R. F.
    Mueller-Tidow, C.
    Dreger, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 51 - 51
  • [39] Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia
    Brancati, Serena
    Gozzo, Lucia
    Romano, Giovanni Luca
    Vetro, Calogero
    Dulcamare, Ilaria
    Maugeri, Cinzia
    Parisi, Marina
    Longo, Laura
    Vitale, Daniela Cristina
    Di Raimondo, Francesco
    Drago, Filippo
    BLOOD, 2021, 138
  • [40] Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient
    Kaya, Sureyya Yigit
    Bektas, Sebnem
    Askin, Abdullah Emre
    Aydin, Berrin Balik
    Mutlu, Yasa Gul
    Sevindik, Omur Gokmen
    ANNALS OF HEMATOLOGY, 2023, 102 (06) : 1599 - 1600
12345